Short answer
KORU Medical Systems, Inc. (KRMD) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $12M (up 18.2% year over year) with net income of $252,449.
Q2 2026 key financials · XBRL
- Revenue
- $12M
- +18.2% YoY · +2.4% QoQ
- Net income
- $252,449
- +222.0% YoY · +131.3% QoQ
- Operating margin
- 5.2%
- Gross margin
- 65.1%
- EPS (diluted)
- $0.01
- +150.0% QoQ
Source: XBRL data from the KORU Medical Systems, Inc. (KRMD) Q2 2026 10-Q on SEC EDGAR. USD.
KORU Medical Systems, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q2 revenue $12.0M, up 18.2% YoY from $10.2M
- Gross margin 65.1% vs 63.5% YoY
- Best segment International Core $3.5M, up 59.1% YoY
- Worst segment Pharma Services $0.6M, down 35.0% YoY
- Cash $8.3M; six-month operating cash flow $0.2M vs $(0.7)M YoY
- Outlook: liquidity sufficient through next twelve months, with potential future debt or equity financing needs
Risk Factors
- No material changes in risk factors identified; 10-Q references risks from the December 31, 2025 Form 10-K
- Unregistered equity issuance risk from May 18 asset acquisition; 125,628 shares issued under Regulation D
- Share-transfer restriction risk; issued shares subject to an 18-month transfer restriction
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other KORU Medical Systems, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.